The treatment of elderly patients with chronic lymphocytic leukemia and comorbid conditions requires an assessment of individual patient factors an......READ MORE
Advances in the understanding of the pathobiology of chronic lymphocytic leukemia (CLL) have led to the success of targeted therapies such as Bruto......READ MORE
The BCL-2 inhibitor venetoclax has an established role in the treatment of chronic lymphocytic leukemia (CLL), but its utilization in the community......READ MORE
Many patients with newly diagnosed chronic lymphocytic leukemia (CLL) do not require treatment initially, and some may never require treatment at a......READ MORE
by John C. Byrd, MD; Ian W. Flinn, MD, PhD; and Jeff Sharman, MD
Chronic lymphocytic leukemia (CLL) treatment can impact quality of life (QOL) in many different ways. Psychological aspects of treatment may be imp......READ MORE
by John C. Byrd, MD; Ian W. Flinn, MD, PhD; and Jeff Sharman, MD
Our featured experts describe the latest data that guide decisions on initial therapy for the treatment of chronic lymphocytic leukemia (CLL). Incr......READ MORE